MARKET

LLY

LLY

Lilly Eli & Co
NYSE
1,010.31
-4.18
-0.41%
After Hours: 1014.93 +4.62 +0.46% 19:58 12/05 EST
OPEN
1,023.84
PREV CLOSE
1,014.49
HIGH
1,027.39
LOW
1,004.00
VOLUME
2.50M
TURNOVER
--
52 WEEK HIGH
1,111.99
52 WEEK LOW
621.50
MARKET CAP
955.13B
P/E (TTM)
49.41
1D
5D
1M
3M
1Y
5Y
1D
Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?
The Motley Fool · 14h ago
Is It Too Late To Consider Eli Lilly After Its Massive Multi Year Share Price Surge
Simply Wall St · 1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of December 7
Seeking Alpha · 1d ago
Do These 3 Healthcare Stocks Need a Checkup?
NASDAQ · 1d ago
Eli Lilly shares fell for seven consecutive sessions
Seeking Alpha · 1d ago
Notable Friday Option Activity: BKNG, CAR, LLY
NASDAQ · 1d ago
Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
TipRanks · 1d ago
Meet the Supercharged Growth Stock That Could Join Apple, Nvidia, Microsoft, and Alphabet in the $2 Trillion Club by 2028
The Motley Fool · 1d ago
More
About LLY
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD).

Webull offers Eli Lilly And Co stock information, including NYSE: LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.